Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion type Assertion NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_head.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion description "[One hundred and twenty-seven patients (69 males, 58 females) with type I diabetes were evaluated for ABO and Rh blood groups, chlorpropamide alcohol flush (CPAF) and acetylator phenotype (AP) as well as for life-habits (smoking, alcohol use, diet and drug compliance), metabolic indexes (M-value, HbA1, cholesterol and triglyceride levels) and late complications of diabetes [coronary heart disease (CHD), arterial hypertension (AH), retinopathy and nephropathy].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_provenance.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion evidence source_evidence_literature NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_provenance.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion SIO_000772 3471027 NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_provenance.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion wasDerivedFrom befree-2016 NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_provenance.
- NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_assertion wasGeneratedBy ECO_0000203 NP1302166.RA5FTVMLk00TEDWxF3LRLGc2bq7XpdNL2JIqnX0g8x68U130_provenance.